BTAI icon

BioXcel Therapeutics

93 hedge funds and large institutions have $283M invested in BioXcel Therapeutics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

27% less capital invested

Capital invested by funds: $388M → $283M (-$105M)

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

Holders
93
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.8M
Puts
$2.88M
Net Calls
Net Calls Change

Top Buyers

1 +$9.93M
2 +$8.37M
3 +$2.32M
4
Bank of America
Bank of America
North Carolina
+$1.57M
5
BlackRock
BlackRock
New York
+$1.48M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$262K
52
$250K
53
$249K
54
$240K
55
$238K
56
$235K
57
$213K
58
$203K
59
$199K
60
$186K
61
$171K
62
$169K
63
$166K
64
$128K
65
$110K
66
$104K
67
$99.3K
68
$95K
69
$85K
70
$76K
71
$70K
72
$64K
73
$51K
74
$48K
75
$46K